Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials

Somedeb Ball, Anita Sultan, Myo H. Zaw, Kyaw Z. Thein

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)518-520
Number of pages3
JournalJournal of Geriatric Oncology
Volume10
Issue number3
DOIs
StatePublished - May 2019
Externally publishedYes

Keywords

  • Acute myeloid leukemia
  • Meta-analysis
  • Niraparib
  • Ovarian neoplasms
  • PARP inhibitors
  • Rucaparib

ASJC Scopus subject areas

  • Oncology
  • Geriatrics and Gerontology

Cite this